Delivery Order SPE2DB22D2211-SPE2DB25FRYSH

Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,114.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 0.15 mg epinephrine auto-injectors, with a performance period extending through April 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This is a $1,229.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injector devices. The contract has an ultimate completion date of June 11, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,129.01 firm fixed-price delivery order is for the supply of Epinephrine 0.3 mg auto-injectors, with a completion date of August 9, 2024. This contract is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which covers a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,089.60, is for the delivery of epinephrine 0.3 mg auto-injectors and has a completion date of March 11, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,596.24 firm fixed-price contract is for the supply of 4,567,997,553 units of epinephrine 0.3 mg auto-injectors. The award has an ultimate completion date of April 23, 2025 and is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide epinephrine 0.3 mg auto-injectors. The $1,710.38 contract has a completion date of December 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $1,373.67 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,556,974,597 units of Epinephrine 0.3 mg auto-injectors. This contract has an ultimate completion date of April 25, 2022 and was not designated with a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a $10,305.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,242,552 units of Epinephrine 0.3 mg auto-injectors. The contract has a period of performance through May 15, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,592.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,727,625 units of Epinephrine 0.3 mg auto-injector 2-packs. The contract has a firm fixed price and an ultimate completion date of December 17, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), is the prime contractor with no set-aside designation...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,320.50, is for the delivery of 4,567,951,638 units of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRYSH
    Delivery Order

This is a $7,667.16 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Epinephrine 0.3 mg auto-injectors, with a completion date of June 10, 2025.

Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

The contract award is not set aside and is open to full and open competition. Amerisourcebergen, a for-profit organization, is the prime contractor with no major subcontractors mentioned.

Generated 9/8/25, 9:46 AM